Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-02

Clinical Trial Update: CorEvitas Japan Rheumatoid Arthritis (RA) Registry

View source ↗

Summary

An observational registry in Japan for rheumatoid arthritis sponsored by CorEvitas, currently active but not recruiting, to collect real-world data on RA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: CorEvitas | Conditions: Rheumatoid Arthritis | Status: ACTIVE_NOT_RECRUITING